1. Strategic Guidance | Risk-Managed | Cross-Border Execution

Belbahi & Garner Ltd provides strategic advisory services across the global oil and gas markets, combining in-depth analysis, risk management, regulatory compliance, and strategic procurement. We guide corporates, trading desks, refiners, and institutional investors in evaluating, structuring, and securing high-value international transactions.

Our services help clients understand global supply and demand dynamics, anticipate price developments, and navigate regulatory requirements. We assist in designing compliant and prudent transaction frameworks, assessing counterparties through KYC, AML, and due diligence protocols, and aligning procurement and vendor qualification with corporate and regulatory standards.

This approach ensures global energy transactions are executed with clarity, confidence, and strategic oversight, without Belbahi & Garner Ltd taking a direct transactional role.

2. Strategic Insights | Risk Intelligence | Cross-Border Capital Solutions

We advise corporates, institutional investors, and private capital participants on the analysis and structuring of international investment opportunities.

Our approach is grounded in structured market intelligence, sector analysis, and risk assessment frameworks designed to support disciplined capital allocation in complex global environments.

We assist clients in evaluating opportunities, assessing exposure, and structuring cross-border investment initiatives with regulatory awareness and strategic discipline.

We also integrate a Marketing & Deal Origination capability, focused on market positioning, opportunity identification, and cross-border transaction sourcing across global energy and commodity markets.

This includes structured intelligence, counterparty mapping, and analytical frameworks used to identify and qualify potential transaction opportunities.

3. Clarity | Compliance | Decision Support

Belbahi & Garner Ltd supports international businesses, trading groups, and institutional stakeholders through independent strategic advisory, compliance-oriented analysis, and cross-border decision-support services.

We assist clients in evaluating counterparties, transactional structures, procurement strategies, and operational exposures associated with complex international commercial activities. Our advisory approach is designed to strengthen commercial readiness, reinforce compliance oversight, and support disciplined strategic decision-making across global markets.

Through structured analysis, market intelligence, and risk awareness methodologies, we help clients navigate international opportunities with clarity, governance, and operational confidence.

Belbahi & Garner Ltd acts solely as an independent strategic advisor and does not participate as broker, intermediary, fiduciary, or transactional principal.

4. Secure & Verified Global B2B Cryptocurrency Advisory

Belbahi & Garner Ltd facilitates secure, compliant, and verified B2B cryptocurrency advisory, serving institutional investors, corporates, and strategic partners operating in regulated digital asset environments.

All engagements follow a risk-aware advisory framework, leveraging regulated escrow structures or institutionally secured exchange infrastructure. We act strictly as an advisory intermediary and do not custody or trade digital assets.

Our services are designed for institutional and corporate clients operating under strict compliance and regulatory expectations in the US and Europe.

Option 1 – FINMA-Approved Crypto Escrow Advisory

We advise and coordinate transactions using a FINMA-approved law firm escrow account, acting as a neutral intermediary.

Key Benefits

  • Legal oversight and contractual protection

  • Asset release only upon fulfillment of agreed conditions

  • Blockchain verification without wallet disclosure

Option 2 – Secure Exchange Platform (Fireblocks & Coincover)

Clients may transact via a dedicated, institutionally secured exchange platform.

Key Features

  • Mandatory KYC / KYB onboarding

  • Custody and cryptographic protection

  • Instant execution in a compliant environment

5. Turnkey Pharmaceutical Project Infrastructure

Belbahi & Garner Ltd is a strategic advisory firm specialized in the structuring, coordination, and engineering of complex pharmaceutical and healthcare infrastructure projects at international scale.

As part of its mandate, the firm represents a high-level international pharmaceutical industrial consortium dedicated to the development and execution of integrated turnkey industrial projects, including the full regulatory and operating licensing framework required for commissioning and commercial operation.

The advisory platform acts as a central strategic interface between sovereign wealth funds, institutional investors, public authorities, and the international industrial consortium responsible for project delivery.

Integrated Industrial  Global EPC Framework

The consortium operates under a global Engineering, Procurement & Construction (EPC) framework adapted to the pharmaceutical and healthcare infrastructure sector, enabling end-to-end project delivery under a fully integrated execution model.

This framework covers the complete project lifecycle, from strategic definition and feasibility studies through engineering design, construction, equipment procurement, system integration, validation, commissioning, and operational readiness, including associated logistics systems.

The objective is the delivery of fully operational pharmaceutical infrastructure assets that are compliant with applicable international regulatory standards and suitable for institutional-grade deployment.

Turnkey  Pharmaceutical  Projects

The portfolio of projects encompasses the development of complete pharmaceutical manufacturing ecosystems designed for industrial scalability, regulatory compliance, and long-term operational sustainability.

These infrastructures support a broad range of pharmaceutical production capabilities, including general and specialized medicines, sterile and injectable products, biological and biotechnological therapies, high-complexity treatments such as oncology, as well as solid, liquid, and lyophilized dosage forms.

Industrial Infrastructure Scope

The projects integrate all essential components required for modern pharmaceutical manufacturing environments, including GMP-compliant production facilities, multi-line and multi-product industrial platforms, controlled-environment manufacturing units, and biopharmaceutical production centers.

These facilities are designed as fully integrated industrial systems aligned with international healthcare and life sciences standards.

Manufacturing Systems

The industrial scope includes the production of solid dosage forms, liquid formulations, sterile injectables, and aseptic manufacturing processes.

It further incorporates lyophilization technologies, automated packaging and conditioning systems, and high-capacity production lines designed in accordance with international industrial benchmarks.

Technical Infrastructure

Projects include complete technical and utility systems required for regulated pharmaceutical production environments, including GMP-compliant cleanrooms, controlled atmospheric zones, pharmaceutical HVAC systems, and critical utilities such as purified water systems, clean steam, and compressed air networks.

These systems are complemented by advanced automation, process control, and digital monitoring infrastructures ensuring operational reliability and regulatory compliance.

Pharmaceutical Logistics Infrastructure

The integrated solutions extend to pharmaceutical logistics and supply chain systems, including regulated storage facilities, domestic and international distribution networks, end-to-end supply chain management systems, and healthcare logistics platforms designed for temperature-sensitive and regulated products.

International Industrial Consortium

The consortium constitutes a fully integrated industrial ecosystem covering the entire pharmaceutical value chain.

It brings together capabilities in engineering and construction of GMP-compliant pharmaceutical facilities, delivery of complex industrial infrastructure, and development of controlled environments and cleanroom systems.

It also integrates industrial manufacturing capabilities, including sterilization, filling, lyophilization, and automated production systems supported by advanced industrial automation technologies.

The consortium further provides validation and compliance services, including qualification of equipment and facilities, system validation in accordance with GAMP5 and 21 CFR Part 11 standards, and support for international regulatory inspections and audits.

In addition, it encompasses quality assurance and supply chain functions, including pharmaceutical quality control, supplier qualification and sourcing, international healthcare logistics, and full traceability and certification of industrial operations.

Licensing & International Compliance

All projects are developed in accordance with internationally recognized regulatory frameworks, including Good Manufacturing Practices (GMP), United States FDA requirements, European EMA standards, and GAMP5 guidelines for computerized systems.

They further integrate global pharmaceutical quality, safety, and validation standards, along with structured support for the acquisition of production, operational, and regulatory licenses.

Each project is designed to be fully compliant, validated, and ready for immediate industrial commissioning and operational deployment.

6. Secure, Efficient & Tailor-Made Logistics Services Worldwide

Secure, Efficient & Tailor‑Made Logistics Services Worldwide

Belbahi & Garner Ltd delivers secure, efficient, and customized logistics and storage solutions worldwide. Leveraging our trusted global network, we ensure reliable, compliant, and risk-managed transport and storage for businesses across international markets.